Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.25
-0.15 (-0.39%)
Jun 26, 2025, 11:59 AM CST
-29.69%
Market Cap 27.35B
Revenue (ttm) 1.63B
Net Income (ttm) -13.57M
Shares Out 712.26M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend 0.75 (1.95%)
Ex-Dividend Date Aug 2, 2024
Volume 77,400
Average Volume 863,577
Open 38.25
Previous Close 38.40
Day's Range 38.25 - 38.80
52-Week Range 30.60 - 59.60
Beta 0.43
RSI 49.13
Earnings Date Aug 12, 2025

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising of antipyretic and analgesic, bronchodilator, anti-inflammatory preparations, anti-allergic agent, expectorant, narcotic antitussive and expectorant, gastrointestinal preparations, non-narcotic antitussive and expectorant, and other medicines. It also offers central nervous system medication consisting of cerebrovascular disease, dementia, depressi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

In 2024, Center Laboratories's revenue was 1.62 billion, an increase of 16.06% compared to the previous year's 1.39 billion. Losses were -1.10 billion, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.